Antares Pharma, Inc. · Ewing, NJ United States ·(NYSE Alternext: AIS)
Company Description
View Antares Pharma, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug delivery platforms, including topical gels, orally-administered disintegrating tablets, and mini-needle injection systems.
To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Antares Pharma, Inc. Financials
| Company Type | Public - NYSE Alternext: AIS Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $5.7 |
| 2008 Employees | 24 |
Antares Pharma, Inc. Executives
11 executives listed for Antares Pharma, Inc.'s Ewing, NJ location.
| Title | Name & Bio | Contact |
| Chairman | Leonard Jacob | Network |
| President, CEO, and Director | Paul Wotton | Network |
| SVP, CFO, and Secretary | Robert Apple | Network |
Competition
Competitive Landscape for Antares Pharma, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Antares Pharma, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!